NDC | 0093-2748-65, 0093-2748-92, 0093-2748-94 |
Set ID | 2a8cc600-4995-4279-b169-206d7ef8a93f |
Category | HUMAN OTC DRUG LABEL |
Packager | Teva Pharmaceuticals USA, Inc. |
Generic Name | |
Product Class | |
Product Number | |
Application Number | ANDA075512 |
- SPL UNCLASSIFIED SECTION
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Allergy alert: Do not use if you are allergic to famotidine or
other acid reducers.Do not use
- if you have trouble or pain swallowing food, vomiting
with blood, or bloody or black stools. These may be
signs of a serious condition. See your doctor. - with other acid reducers
Ask a doctor before use if you have
- had heartburn over 3 months. This may be a
sign of a more serious condition. - heartburn with lightheadedness, sweating, or dizziness
- chest pain or shoulder pain with shortness of breath;
sweating; pain spreading to arms, neck or shoulders;
or lightheadedness - frequent chest pain
- frequent wheezing, particularly with heartburn
- unexplained weight loss
- nausea or vomiting
- stomach pain
- if you have trouble or pain swallowing food, vomiting
-
Directions
- adults and children 12 years and over:
- to relieve symptoms, swallow 1 tablet with a glass of
water. Do not chew. - to prevent symptoms, swallow 1 tablet with a glass of
water at anytime from 15 to 60 minutes before eating
food or drinking beverages that cause heartburn - do not use more than 2 tablets in 24 hours
- to relieve symptoms, swallow 1 tablet with a glass of
- children under 12 years: ask a doctor
- adults and children 12 years and over:
-
Other information
- read the directions and warnings before use
-
TAMPER-EVIDENT: Do not use this product if carton has
been opened, if blister backing appears to have been
disturbed, or if individual blister units are broken or torn. - keep the carton. It contains important information.
- store at 20° to 25°C (68° to 77°F)
- protect from moisture
- Inactive ingredients
- Questions?
- Principal Display Panel, Part 1 of 2
- Principal Display Panel, Part 2 of 2
-
INGREDIENTS AND APPEARANCE
FAMOTIDINE
famotidine tablet, film coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0093-2748 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FAMOTIDINE (UNII: 5QZO15J2Z8) (FAMOTIDINE - UNII:5QZO15J2Z8) FAMOTIDINE 10 mg Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4) FD&C RED NO. 40 (UNII: WZB9127XOA) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) STARCH, CORN (UNII: O8232NY3SJ) SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color orange (PEACH) Score no score Shape ROUND Size 9mm Flavor Imprint Code TEVA;2662 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0093-2748-65 3 in 1 CARTON 01/08/2015 11/26/2021 1 10 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:0093-2748-92 5 in 1 CARTON 01/08/2015 11/26/2021 2 10 in 1 BLISTER PACK; Type 0: Not a Combination Product 3 NDC:0093-2748-94 7 in 1 CARTON 01/08/2015 11/26/2021 3 10 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA075512 01/08/2015 11/26/2021 Labeler - Teva Pharmaceuticals USA, Inc. (001627975)